← back to search

Weon‐Kyoo You

ABL Bio (South Korea) · KR
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, Pancreatic and Hepatic Oncology Research, and Cell Adhesion Molecules Research.
h-index
23
citations
2,387
works
71
NIH funding
primary concept
email

Recent publications

Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Cancer Discovery 2012cited by 416position: middledoi
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan
Breast Cancer Research 2012cited by 83position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Vikash Bhagwandin · Varian Medical Systems (United States)1 papers (2012–2012)Ryan M. Naylor · Mayo Clinic1 papers (2012–2012)Lawrence J.T. Young · University of California, Davis1 papers (2012–2012) · 1 papers (2012–2012)Donald M. McDonald · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2012–2012)Krissa A. Gibby · Georgetown University1 papers (2012–2012)Casey W. Williamson · University of California San Diego1 papers (2012–2012)Ying Wei · Fanjingshan National Nature Reserve1 papers (2012–2012)Sébastien P. Tabruyn · TransCure BioServices (France)1 papers (2012–2012)Barbara Sennino · Sunesis (United States)1 papers (2012–2012)Harold A. Chapman · Pulmonary and Allergy Associates1 papers (2012–2012)Toshina Ishiguro‐Oonuma · Iwate University1 papers (2012–2012) · 1 papers (2012–2012)Robert D. Cardiff · National Center for Infectious Diseases1 papers (2012–2012)Kuniko Kadoya · AbbVie (United States)1 papers (2012–2012)Lesley G. Ellies · The University of Western Australia1 papers (2012–2012)Dana T. Aftab · Exelixis (United States)1 papers (2012–2012)James G. Christensen · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)Hildur R. Helgadottir · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)